Nuvilab Earns Top Honors in Korea’s AI Startup 100, Transforming Food Industry with AI Food Scanner 3.0

SEOUL, South Korea, Nov. 8, 2023 /PRNewswire/ — Nuvilab, the South Korean AI pioneer in food digitalization locked in its spot for Korea AI Startup 100. The Korea AI Startup 100 recognizes aspiring startups in South Korea to foster the healthy growth of the next-generation AI industry ecosystem.


Nuvilab’s Food Digitalization Health Care Services Earns a Spot in Korea’s AI Startup 100

Strictly evaluated by AI professionals from the Korea Advanced Institute of Science and Technology (KAIST) and KT Economics & Management Research Institute, Nuvilab was recognized for its innovative personalized AI solutions within the healthcare industry.

The new Dataware “AI Food Scanner 3.0” conceived by Nuvilab, features a quick and accurate food intake and waste analysis with personalized nutrition solutions sent directly to individuals’ mobile devices. The solutions are just as applicable for use within hospitality where a significant amount of food waste is generated daily.

Within 0.97 seconds of scanning, Nuvilab is committed to providing three solutions for their clients, which include personalized nutrient consumption analysis, carbon emissions management solutions, and food overproduction in kitchens, tackling the global issue of climate change.

Nuvilab is already creating immense impacts in a wide array of industries in Korea including healthcare, hospitality, education, and much more, improving clients’ food service operations and further impacting cost savings and environmental benefits.

Now on the verge of global expansion, Nuvilab is boasting its partnerships with top hospitality groups worldwide with current partnerships with Aramark, Fraser Health Authority of Canada, and Alexandra Hospital of Singapore, seeking to expand with more.

For more information, please visit Nuvilab’s website or contact [email protected] 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.